Kevin Caliendo
Stock Analyst at UBS
(4.18)
# 413
Out of 5,182 analysts
207
Total ratings
65.05%
Success rate
8.5%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Buy | $10 → $5 | $2.31 | +116.45% | 4 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Buy | $48 → $57 | $43.88 | +29.90% | 2 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $10 → $12 | $6.40 | +87.50% | 7 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Neutral | $79 → $87 | $74.86 | +16.22% | 7 | Feb 25, 2026 | |
| DGX Quest Diagnostics | Maintains: Neutral | $190 → $210 | $198.96 | +5.55% | 17 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Neutral | $175 → $185 | $171.87 | +7.64% | 20 | Feb 5, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $17 → $16 | $11.64 | +37.46% | 13 | Feb 3, 2026 | |
| NVST Envista Holdings | Maintains: Neutral | $22 → $25 | $25.81 | -3.14% | 5 | Feb 3, 2026 | |
| ALHC Alignment Healthcare | Maintains: Neutral | $18 → $21 | $18.67 | +12.48% | 9 | Jan 14, 2026 | |
| CVS CVS Health | Maintains: Buy | $96 → $97 | $73.28 | +32.37% | 11 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $77 → $79 | $63.25 | +24.90% | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $380 → $415 | $320.96 | +29.30% | 4 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.25 → $4 | $2.07 | +93.24% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $920 → $980 | $856.77 | +14.38% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $220 | $212.62 | +3.47% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $378 → $430 | $281.36 | +52.83% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $320 | $274.46 | +16.59% | 7 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $143.36 | +18.58% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $5.57 | +61.58% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $275.69 | +41.46% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $182.65 | +36.87% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $35.40 | +123.16% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $302.61 | +90.01% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $240.97 | -25.30% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $5.32 | +1,253.38% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $29.82 | -63.11% | 4 | May 4, 2021 |
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $5
Current: $2.31
Upside: +116.45%
Medline
Feb 26, 2026
Maintains: Buy
Price Target: $48 → $57
Current: $43.88
Upside: +29.90%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.40
Upside: +87.50%
Henry Schein
Feb 25, 2026
Maintains: Neutral
Price Target: $79 → $87
Current: $74.86
Upside: +16.22%
Quest Diagnostics
Feb 11, 2026
Maintains: Neutral
Price Target: $190 → $210
Current: $198.96
Upside: +5.55%
Align Technology
Feb 5, 2026
Maintains: Neutral
Price Target: $175 → $185
Current: $171.87
Upside: +7.64%
DENTSPLY SIRONA
Feb 3, 2026
Maintains: Buy
Price Target: $17 → $16
Current: $11.64
Upside: +37.46%
Envista Holdings
Feb 3, 2026
Maintains: Neutral
Price Target: $22 → $25
Current: $25.81
Upside: -3.14%
Alignment Healthcare
Jan 14, 2026
Maintains: Neutral
Price Target: $18 → $21
Current: $18.67
Upside: +12.48%
CVS Health
Dec 10, 2025
Maintains: Buy
Price Target: $96 → $97
Current: $73.28
Upside: +32.37%
Nov 10, 2025
Maintains: Neutral
Price Target: $77 → $79
Current: $63.25
Upside: +24.90%
Nov 7, 2025
Maintains: Buy
Price Target: $380 → $415
Current: $320.96
Upside: +29.30%
Nov 6, 2025
Maintains: Neutral
Price Target: $4.25 → $4
Current: $2.07
Upside: +93.24%
Nov 6, 2025
Maintains: Buy
Price Target: $920 → $980
Current: $856.77
Upside: +14.38%
Oct 31, 2025
Maintains: Buy
Price Target: $185 → $220
Current: $212.62
Upside: +3.47%
Oct 29, 2025
Maintains: Buy
Price Target: $378 → $430
Current: $281.36
Upside: +52.83%
Oct 29, 2025
Maintains: Buy
Price Target: $325 → $320
Current: $274.46
Upside: +16.59%
Oct 24, 2025
Maintains: Neutral
Price Target: $180 → $170
Current: $143.36
Upside: +18.58%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $5.57
Upside: +61.58%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $275.69
Upside: +41.46%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $182.65
Upside: +36.87%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $35.40
Upside: +123.16%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $302.61
Upside: +90.01%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $240.97
Upside: -25.30%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $5.32
Upside: +1,253.38%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $29.82
Upside: -63.11%